Dynavax Technologies Corporation
Doing business as Dynavax Technologies CORP
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersEmeryville, CA
US patents65
SAM.gov UEIJA7GSG397PL1
CAGE code4BYD4
Incorporated inDE
LEI549300T5URIXWDILX594
- vaccines
- adjuvant technology
- infectious
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
65 US patents granted 2001–2025, 8 of them in the five years to SEP 2025.
Pharmaceuticals 61Organic fine chemistry 1Measurement 1Biotechnology 1
- Toll-like receptor antagonist compounds and methods of useUS 12,378,255 · granted AUG 5, 2025
- Immunogenicity of a CpG-adjuvanted recombinant plague vaccineUS 12,364,745 · granted JUL 22, 2025
- Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)US 12,296,002 · granted MAY 13, 2025
- Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereofUS 11,981,670 · granted MAY 14, 2024
- Toll-like receptor antagonist compounds and methods of useUS 11,827,641 · granted NOV 28, 2023
Newest 5 shown · Granted to Dynavax Technologies Corporation · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Dynavax Technologies Corporation | Emeryville | CA | — | ACTIVE |
WARN Act notices
- Layoff notice effective JUL 23, 2019 · 80 employees · Dynavax Technologies Corporation
Filed with the state under the federal WARN Act · WARN Act notices feed, CC BY 4.0
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.